22-36922079-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000395.3(CSF2RB):​c.-129T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0238 in 805,266 control chromosomes in the GnomAD database, including 317 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 50 hom., cov: 33)
Exomes 𝑓: 0.025 ( 267 hom. )

Consequence

CSF2RB
NM_000395.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.27
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-36922079-T-G is Benign according to our data. Variant chr22-36922079-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 1215938.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0196 (2988/152250) while in subpopulation SAS AF = 0.0269 (130/4832). AF 95% confidence interval is 0.0249. There are 50 homozygotes in GnomAd4. There are 1493 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RBNM_000395.3 linkc.-129T>G 5_prime_UTR_variant Exon 2 of 14 ENST00000403662.8 NP_000386.1 P32927-1Q6NSJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RBENST00000403662.8 linkc.-129T>G 5_prime_UTR_variant Exon 2 of 14 5 NM_000395.3 ENSP00000384053.3 P32927-1

Frequencies

GnomAD3 genomes
AF:
0.0197
AC:
2991
AN:
152132
Hom.:
50
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00459
Gnomad AMI
AF:
0.0231
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.0585
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0271
Gnomad FIN
AF:
0.0354
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0259
Gnomad OTH
AF:
0.0272
GnomAD4 exome
AF:
0.0247
AC:
16141
AN:
653016
Hom.:
267
Cov.:
9
AF XY:
0.0250
AC XY:
8516
AN XY:
340006
show subpopulations
African (AFR)
AF:
0.00577
AC:
101
AN:
17500
American (AMR)
AF:
0.0152
AC:
509
AN:
33432
Ashkenazi Jewish (ASJ)
AF:
0.0613
AC:
1194
AN:
19486
East Asian (EAS)
AF:
0.0000626
AC:
2
AN:
31944
South Asian (SAS)
AF:
0.0269
AC:
1684
AN:
62612
European-Finnish (FIN)
AF:
0.0290
AC:
987
AN:
33980
Middle Eastern (MID)
AF:
0.0352
AC:
93
AN:
2642
European-Non Finnish (NFE)
AF:
0.0257
AC:
10729
AN:
418088
Other (OTH)
AF:
0.0253
AC:
842
AN:
33332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
822
1645
2467
3290
4112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0196
AC:
2988
AN:
152250
Hom.:
50
Cov.:
33
AF XY:
0.0201
AC XY:
1493
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00457
AC:
190
AN:
41556
American (AMR)
AF:
0.0160
AC:
245
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0585
AC:
203
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.0269
AC:
130
AN:
4832
European-Finnish (FIN)
AF:
0.0354
AC:
376
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0259
AC:
1760
AN:
67982
Other (OTH)
AF:
0.0265
AC:
56
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
159
318
478
637
796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0194
Hom.:
6
Bravo
AF:
0.0178
Asia WGS
AF:
0.00953
AC:
33
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 26, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.38
DANN
Benign
0.43
PhyloP100
-1.3
PromoterAI
0.015
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117689490; hg19: chr22-37318121; API